Since SRSF1 and SRSF2 have been previously reported to be involved in promoting the progression of HCC [29,30], our study implied the strongest positive correlation of SRSF11 with sorafenib IC50 (Figure 7B). This evidence concerns the gene SRSF11 and hepatocellular carcinoma.